Abstract: A fluid control device includes a main body block including a first flow passage, and a second flow passage, a first and second fluid control units installed on an installation surface of the main body block. The first and second flow passages include a first portion extending along a first direction and a second flow passage portion orthogonal to the first direction. The second portion is formed of a hole extending from a side surface of the main body block and a sealing member.

Abstract: A detection device includes a transceiver and a detector. The transceiver causes an ultrasonic sensor used in a vehicle to alternately transmit a first transmission wave having a first amplitude level and a second transmission wave having a second amplitude level that is larger than the first amplitude level. The transceiver receives, from the ultrasonic sensor, a first received signal of the first transmission wave and a second received signal of the second transmission wave. The detector detects an obstacle based on the first received signal or the second received signal having a reception level larger than a predetermined threshold. The detector detects the obstacle based on the second received signal that does not include a second road surface reflected wave out of the second received signal.

Abstract: An image forming apparatus includes an image reader, a controller, and an output section. The image reader reads a document at a highest resolution. The controller generates, from first image data obtained by reading of the document performed at the highest resolution, second image data having a resolution that is lower than the highest resolution, and sets a resolution of output image data based on a result of comparison between a first recognition result, which is a recognition result of character recognition processing performed on the first image data, and a second recognition result, which is a recognition result of character recognition processing performed on the second image data.

Abstract: A control system constructed so that a machine tool and a high-order server configured to manage the machine tool are connected through a communication line determines the arrangement of a control process in the respective execution environments of the machine tool and the high-order server, based on an execution condition for the execution of the control process available in machining performed in the machine tool and machining information on the machining in the machine tool.

Abstract: A sensor mounting state determination device includes distance measurement section that measures a distance to a road surface based on time from transmission of a transmission wave to reception of a reflection wave by an ultrasonic sensor that is mounted to a vehicle to transmit a transmission wave toward a road surface and receive a reflection wave reflected off the road surface. There is further provided a determination section configured to determine not only that the ultrasonic sensor is correctly mounted when the distance measured by the distance measurement section is identical to a predetermined distance, but also that the ultrasonic sensor is incorrectly mounted when the distance measured by the distance measurement section is not identical to the predetermined distance.

Abstract: There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which encodes the amino acid sequence of the antibody; a vector which comprises the DNA; hybridomas and antibody producing cells which produce the antibody; a method of producing the antibody; a composition which comprises the antibody or the antibody fragment; a treatment method and a diagnostic method of an allergic disease, an autoimmune disease, a disease accompanied by at least one of increase and hyperergasia of eosinophils; a disease accompanied by at least one of increase and hyperergasia of Th2 cells using the antibody or the antibody fragment; and a medicine and a diagnostic agent which comprise the antibody or the antibody fragment.

Abstract: A mobile electronic device comprises a display, an operation detector, and a processor. The operation detector is capable of detecting a first touch operation and a second touch operation on the display performed by a part of a human body. The processor is configured to execute a control process responsive to the first touch operation and the second touch operation. The part of the human body performing the second touch operation is located in a position farther from the display than a position of the part of the human body performing the first touch operation. The processor is configured to execute the control process while handling the first touch operation and the second touch operation performed continuously as a single touch operation, depending on a time lag between the first touch operation and the second touch operation.

Abstract: The present invention relates to an antibody specifically binding to human growth arrest specific 6 (hGas6). Specifically, the present invention relates to a monoclonal antibody or an antibody fragment thereof which binds to at least one of amino acid residues at positions 314, 315, and 316 of human Gas6, a nucleic acid comprising a nucleotide sequence encoding the antibody or the antibody fragment, a transformed cell comprising a vector comprising the nucleic acid, a method for producing the antibody or the antibody fragment, a reagent for detection or assay of Gas6, comprising the antibody or the antibody fragment, a therapeutic agent or a diagnostic agent for a Gas6-related disease, comprising the antibody or the antibody fragment as an active ingredient, and use of the antibody or the antibody fragment for the production of a therapeutic agent or a diagnostic agent for a Gas6-related disease.

Abstract: An image forming apparatus includes a generation section, an image forming section, and a size determining section. The generation section divides a first image to generate a plurality of second images. The image forming section forms the second images on a plurality of sheets, respectively. The size determining section determines a size of a margin area allocated to at least one of the sheets. The image forming section forms the second images on the sheets, respectively, so that the second images are placed in a designated area on a combined sheet that is to be formed by combining the sheets. The size determining section determines the size of the margin area based on sizes of the designated area and the first image.

Abstract: There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which encodes the amino acid sequence of the antibody; a vector which comprises the DNA; hybridomas and antibody producing cells which produce the antibody; a method of producing the antibody; a composition which comprises the antibody or the antibody fragment; a treatment method and a diagnostic method of an allergic disease, an autoimmune disease, a disease accompanied by at least one of increase and hyperergasia of eosinophils; a disease accompanied by at least one of increase and hyperergasia of Th2 cells using the antibody or the antibody fragment; and a medicine and a diagnostic agent which comprise the antibody or the antibody fragment.

Abstract: There has been a need for a neutralizing monoclonal antibody which is useful for antibody therapy effective against ebolavirus. The present invention provides a monoclonal antibody or an antigen-binding fragment thereof, which recognizes an internal fusion loop of ebolavirus GP and is capable of neutralizing the biological activity of ebolavirus.

Abstract: There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which encodes the amino acid sequence of the antibody; a vector which comprises the DNA; hybridomas and antibody producing cells which produce the antibody; a method of producing the antibody; a composition which comprises the antibody or the antibody fragment; a treatment method and a diagnostic method of an allergic disease, an autoimmune disease, a disease accompanied by at least one of increase and hyperergasia of eosinophils; a disease accompanied by at least one of increase and hyperergasia of Th2 cells using the antibody or the antibody fragment; and a medicine and a diagnostic agent which comprise the antibody or the antibody fragment.

Abstract: An image forming apparatus includes a first connection portion, a second connection portion, a communication processing portion, a switch processing portion, and a connection determination processing portion. To the switch processing portion, the first connection portion and the second connection portion are connected in parallel. The switch processing portion breaks a communication path between the second connection portion and the switch processing portion when the facsimile communication process is executed by the communication processing portion. The connection determination processing portion, when a predetermined determination start condition is satisfied, causes the switch processing portion to break the communication path, and then when a predetermined line voltage is applied to the switch processing portion, determines that a connection between the first connection portion and the public switched telephone network is normal.

Abstract: The present invention relates to a therapeutic agent for pulmonary hypertension comprising an interleukin-5 receptor (hereinafter, abbreviated to “IL-5R”)-inhibiting compound and therapeutic method therefor. More specifically, the present invention relates to a therapeutic agent for pulmonary hypertension comprising an antibody or an antibody fragment capable of specifically binding to the extracellular region of IL-5R and a therapeutic method therefor.

Abstract: An image forming apparatus includes a generation section, an image forming section, and a size determining section. The generation section divides a first image to generate a plurality of second images. The image forming section forms the second images on a plurality of sheets, respectively. The size determining section determines a size of a margin area allocated to at least one of the sheets. The image forming section forms the second images on the sheets, respectively, so that the second images are placed in a designated area on a combined sheet that is to be formed by combining the sheets. The size determining section determines the size of the margin area based on sizes of the designated area and the first image.

Abstract: There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which encodes the amino acid sequence of the antibody; a vector which comprises the DNA; hybridomas and antibody producing cells which produce the antibody; a method of producing the antibody; a composition which comprises the antibody or the antibody fragment; a treatment method and a diagnostic method of an allergic disease, an autoimmune disease, a disease accompanied by at least one of increase and hyperergasia of eosinophils; a disease accompanied by at least one of increase and hyperergasia of Th2 cells using the antibody or the antibody fragment; and a medicine and a diagnostic agent which comprise the antibody or the antibody fragment.

Abstract: This obstacle detection device is mounted on a vehicle. This obstacle detection device includes a plurality of ultrasonic sensors, and a detector. The plurality of ultrasonic sensors transmits a plurality of ultrasonic waves of different frequencies to detection areas which overlap with each other at transmission timings which overlap with each other, and each of the ultrasonic sensors receives a returning ultrasonic wave. The detector identifies which one ultrasonic wave of a plurality of ultrasonic waves is reflected as the received returning ultrasonic wave, and detects a position of an obstacle existing around the vehicle.

Abstract: There is provided an anti-human CRTH2 antibody which has desired activity by recognizing and binding to a specific human CRTH2; the antibody fragment; DNA which encodes the amino acid sequence of the antibody; a vector which comprises the DNA; hybridomas and antibody producing cells which produce the antibody; a method of producing the antibody; a composition which comprises the antibody or the antibody fragment; a treatment method and a diagnostic method of an allergic disease, an autoimmune disease, a disease accompanied by at least one of increase and hyperergasia of eosinophils; a disease accompanied by at least one of increase and hyperergasia of Th2 cells using the antibody or the antibody fragment; and a medicine and a diagnostic agent which comprise the antibody or the antibody fragment.

Abstract: A mobile electronic device comprises a display, an operation detector, and a processor. The operation detector is capable of detecting a first touch operation and a second touch operation on the display performed by a part of a human body. The processor is configured to execute a control process responsive to the first touch operation and the second touch operation. The part of the human body performing the second touch operation is located in a position farther from the display than a position of the part of the human body performing the first touch operation. The processor is configured to execute the control process while handling the first touch operation and the second touch operation performed continuously as a single touch operation, depending on a time lag between the first touch operation and the second touch operation.

Abstract: A mobile electronic device comprises a display, an operation detector, and a processor. The operation detector is capable of detecting a first touch operation and a second touch operation on the display performed by a part of a human body. The processor is configured to execute a control process responsive to the first touch operation and the second touch operation. The part of the human body performing the second touch operation is located in a position farther from the display than a position of the part of the human body performing the first touch operation. The processor is configured to set a second mode of not detecting the second touch operation as a detection mode when the first touch operation is detected while a first mode of detecting the first touch operation and the second touch operation is set as the detection mode.